Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Antiviral Research
|
December 16, 2014
Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients
Patricia Echeverria, Montse Guardiola, Marta González, et al.
Atherosclerosis
|
November 3, 2009
APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome
Antoni Castro, Iolanda Lázaro, David M Selva, et al.
International Journal of Molecular Sciences
|
April 28, 2023
Metabolic Overlap between Alzheimer's Disease and Metabolic Syndrome Identifies the <i>PVRL2</i> Gene as a New Modulator of Diabetic Dyslipidemia
Montse Guardiola, Gerard Muntané, Iris Martínez, et al.
The Journal of Rheumatology
|
August 5, 2010
Nuclear magnetic resonance lipoprotein subclasses and the APOE genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus
Marta Gonzàlez, Josep Ribalta, Glòria Vives, et al.
Rheumatology (Oxford, England)
|
August 27, 2020
Low-density lipoprotein from active SLE patients is more atherogenic to endothelial cells than low-density lipoprotein from the same patients during remission
Ricardo Rodríguez-Calvo, Montse Guardiola, Iris Oliva, et al.
Biomolecules
|
January 21, 2022
Characterization of the LPS and 3OHFA Contents in the Lipoprotein Fractions and Lipoprotein Particles of Healthy Men
Pere Rehues, Marina Rodríguez, Judith Álvarez, et al.
Atherosclerosis
|
May 17, 2016
Corrigendum to "APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis" [Atherosclerosis 240/1 (2015) 98-104]
Montse Guardiola, Montserrat Cofán, Isabel de Castro-Orós, et al.
Cardiovascular Diabetology
|
January 9, 2025
Triglyceride-independent associations between circulating levels of apolipoprotein C-III and biomarkers of inflammation
Dídac Llop, Pere Rehues, Silvia Paredes, et al.
Atherosclerosis
|
March 16, 2015
APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis
Montse Guardiola, Montserrat Cofán, Isabel de Castro-Oros, et al.
Plos One
|
August 29, 2015
Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy
Laura Brugnara, Roger Mallol, Josep Ribalta, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Antiviral Research
|
December 16, 2014
Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients
Patricia Echeverria, Montse Guardiola, Marta González, et al.
Atherosclerosis
|
November 3, 2009
APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome
Antoni Castro, Iolanda Lázaro, David M Selva, et al.
International Journal of Molecular Sciences
|
April 28, 2023
Metabolic Overlap between Alzheimer's Disease and Metabolic Syndrome Identifies the <i>PVRL2</i> Gene as a New Modulator of Diabetic Dyslipidemia
Montse Guardiola, Gerard Muntané, Iris Martínez, et al.
The Journal of Rheumatology
|
August 5, 2010
Nuclear magnetic resonance lipoprotein subclasses and the APOE genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus
Marta Gonzàlez, Josep Ribalta, Glòria Vives, et al.
Rheumatology (Oxford, England)
|
August 27, 2020
Low-density lipoprotein from active SLE patients is more atherogenic to endothelial cells than low-density lipoprotein from the same patients during remission
Ricardo Rodríguez-Calvo, Montse Guardiola, Iris Oliva, et al.
Biomolecules
|
January 21, 2022
Characterization of the LPS and 3OHFA Contents in the Lipoprotein Fractions and Lipoprotein Particles of Healthy Men
Pere Rehues, Marina Rodríguez, Judith Álvarez, et al.
Atherosclerosis
|
May 17, 2016
Corrigendum to "APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis" [Atherosclerosis 240/1 (2015) 98-104]
Montse Guardiola, Montserrat Cofán, Isabel de Castro-Orós, et al.
Cardiovascular Diabetology
|
January 9, 2025
Triglyceride-independent associations between circulating levels of apolipoprotein C-III and biomarkers of inflammation
Dídac Llop, Pere Rehues, Silvia Paredes, et al.
Atherosclerosis
|
March 16, 2015
APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis
Montse Guardiola, Montserrat Cofán, Isabel de Castro-Oros, et al.
Plos One
|
August 29, 2015
Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy
Laura Brugnara, Roger Mallol, Josep Ribalta, et al.
Page
of 5